Page last updated: 2024-10-30

mebendazole and Peptic Ulcer

mebendazole has been researched along with Peptic Ulcer in 1 studies

Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.

Peptic Ulcer: Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wilson, KH1
Kauffman, CA1

Other Studies

1 other study available for mebendazole and Peptic Ulcer

ArticleYear
Persistent Strongyloides stercoralis in a blind loop of the bowel. Successful treatment with mebendazole.
    Archives of internal medicine, 1983, Volume: 143, Issue:2

    Topics: Benzimidazoles; Drug Resistance, Microbial; Humans; Intestinal Diseases, Parasitic; Male; Mebendazol

1983